This is the hover veil
Menu
Menu
Home
Living
guidelines
Clinical
flowcharts
Topics
under review
Do you have a clinical question?
About the taskforce
About the guidelines
FAQs
News
Taskforce TV
Contact us
About the taskforce
About the guidelines
FAQs
News
Taskforce TV
Contact us
News
News
Communique
Video
Explainer
Media release
Topics
Aboriginal and Torres Strait Islander people
ACEIs/ARBs
ACEM
ACIPC
ACNN
Acute and Critical Care Panel
Adults
AHPA
Alex Poole
Allied Health Professions Australia
Amanda Gwee
Anakinra
Angiotensin 2 receptor agonist (C21)
Annie Synnot
Antenatal corticosteroids
Anticoagulants
Anticoagulation
Antivirals
ANZ Guidelines
ANZICS
ANZJOG
ANZPID COVID-19 Clinical Reference Group
Aprepitant
ARC
ASCOT
ASID
ATAGI
Australasian Sleep Association
Australia Day honours
Australian and New Zealand Society for Geriatric Medicine
Australian College of Midwives
Australian Commission on Safety and Quality in Health Care
Australian Living Evidence Consortium (ALEC)
Azithromycin
Baloxavir marboxil
Bamlanivimab
Bamlanivimab plus etesevimab
Baricitinib
Basic Life Support
Bebtelovimab
BESSI principles
Breastfeeding
Bromhexine hydrochloride
Budesonide
Burnet
Camostat mesilate
Canakinumab
Cardiac arrest
Cardiac Arrest Working Group
Care of Children
Care of Older People and Palliative Care Panel
Casirivimab plus imdevimab (Ronapreve)
CD24c
CENA
Chemophrophylaxis
Chemoprophylaxis Panel
CHF
Children and adolescents
Chloroquine
Ciclesonide
Clinical flowcharts
CMCS
Cochrane Australia
Colchicine
COMET-ICE
Consumer Panel
Convalescent plasma
Corticosteroids
Corticosteroids (Inhaled)
COVID-19 COS
CPAP/HFNO
CPR
Critical Disease Panel
CT-P59 monoclonal antibody
Darunavir-cobicistat
Decision Tool
Definitions of disease severity
Delayed umbilical cord clamping
Dexamethasone
Disease-modifying treatments
DMTC Panel
Drug treatments
Dutasteride
ECMO
Enisamium
Episode 6
Expert Advisory Group
Extracorporeal membrane oxygenation
Eye protection
Face masks
Facebook
FAQs
Favipiravir
Flowchart
GIN
Global Commission on Evidence
GPs
Guideline Leadership Group
HCW
High-flow nasal oxygen
Hospital and Acute Care Panel
Hydroxychloroquine
Hydroxychloroquine plus azithromycin
Ian Potter Foundation
ICEG
Imatinib
Immunodulatory treatments table
Immunoglobulin
Immunoglobulin plus methylprednisolone
Immunosuppressed
Infection Control Matters Podcast
Infection Prevention and Control (IPC) Panel
Interferon beta-1a
Interferon Gamma
Interferon β-1a (inhaled)
International Women's Day
Intravenous immunoglobulin
IPC
Ivermectin
Jason Roberts
Lancet
Leadership
Lenzilumab
Living Evidence
Long COVID
Lopinavir-ritonavir
Lorraine Anderson
Magnesium Sulfate
Management of cardiac arrest
Mark Morgan
Methods Advisor
Methods Chair
Mild COVID-19
MJA
Molnupiravir (Lagverio)
Monoclonal antibody therapy
Murray PHN
N-acetylcysteine
NCIRS
Neonatal
Neonates
New England Journal of Medicine
New Topics & Questions
NHMRC
NICE
Nicole Allard
Nirmatrelvir plus ritonavir (Paxlovid)
Non-invasive ventilation
NPS MedicineWise
Observational Data Working Group
Oestrogen containing therapies
Oral antivirals
P2/N95 respirators
Paediatric & Adolescent Care
Paediatric & Adolescent Care Panel
Paediatric and Adolescent Care
Paediatric Decision Tool
Paediatric Management
Paediatrics
Palliative and Aged Care Panel
Palliative Care
Palliative Care Working Group
Pathways to Care
Paxlovid prescribing guide
Peginterferon lambda
Personal Protective Equipment (PPE)
PIMS-TS
Podcast
Post-acute COVID-19
Post-COVID-19
post-exposure prophylaxis
Post-viral symptoms
Postnatal
pre-exposure prophylaxis
Pregnancy and perinatal care
Pregnancy and Perinatal Panel
Pregnant & Postpartum women
Pregnant or breastfeeding women
Primary and Chronic Care Panel
Prone positioning
Proxalutimide
Pulse oximeters
RACGP
RANZCOG
RCTs
RECOVERY Trial
Regeneron
REMAP-CAP
Remdesivir (Veklury)
Respiratory
Respiratory management
Respiratory support
Risk classification tool
RMSANZ
Royal Australian College of Surgeons
Rural and remote care
Ruxolitinib
Sabizabulin
Samantha Chakraborty
Sarilumab
Senior Clinical Fellow
Senior Evidence Officer
severe-critical COVID-19
SMS notifications
Sofosbuvir plus daclatasvir
Sotrovimab
Special populations
Steering Committee
Steroids
subcutaneous casirivimab plus imdevimab
Subscription
Tari Turner
TaskforceTV
Team Profile
Telmisartan
TGA
THANZ
The Alfred
The Conversation
Thromboembolism
Timing of surgery
Tixagevimab plus cilgavimab (Evusheld)
Tocilizumab
Tofacitinib
Tracheostomy
Treatment
TSANZ
Umifenovir
Unvaccinated
Vaccination
Vaccine
Venous thromboembolism (VTE) prophylaxis
Videolaryngoscopy
Vitamin C
Vitamin D
Webinar
Zinc
Featured
COVID-19 Research Pipeline
STUDIES
Cochrane COVID-19 Study Register
167,328
Registered/ Published
RCT
s
covid-nma.com
4,409
Registered
704
Published
SYSTEMATIC REVIEWS
Prospero
6,512
Registered
As at 19 August 2022
Tweets by evidenceCOVID19
FILTERED BY > Rural and remote care
Clear filter
Communique #68
22 July, 2022
Click for the latest Taskforce news:
Communique
